Page last updated: 2024-08-22

didodecyldimethylammonium and Leukemia L 1210

didodecyldimethylammonium has been researched along with Leukemia L 1210 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lee, A; Lee, RJ; Lu, Y; Wu, J	1

Other Studies

1 other study(ies) available for didodecyldimethylammonium and Leukemia L 1210

Article	Year
Vascular targeting of doxorubicin using cationic liposomes. International journal of pharmaceutics, 2007, Jun-07, Volume: 337, Issue:1-2 Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Cations; Cell Survival; Chemistry, Pharmaceutical; Doxorubicin; Drug Compounding; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Injections, Intravenous; Leukemia L1210; Lipids; Liposomes; Mice; Mice, Inbred DBA; Particle Size; Polyethylene Glycols; Quaternary Ammonium Compounds; Tissue Distribution	2007

Article

Year

Vascular targeting of doxorubicin using cationic liposomes.

International journal of pharmaceutics, 2007, Jun-07, Volume: 337, Issue:1-2

Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Cations; Cell Survival; Chemistry, Pharmaceutical; Doxorubicin; Drug Compounding; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Injections, Intravenous; Leukemia L1210; Lipids; Liposomes; Mice; Mice, Inbred DBA; Particle Size; Polyethylene Glycols; Quaternary Ammonium Compounds; Tissue Distribution

2007